---All---
  • ---All---
  • Accession
  • Catalog #

C9orf89 Antibody (N-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP18337a 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP18337a-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

C9orf89 Antibody (N-term) - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ96LW7
Other AccessionQ9D1I2, NP_115686.3
ReactivityHuman
PredictedMouse
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW25589 Da

C9orf89 Antibody (N-term) - Additional info

Gene ID 84270
Other Names
C9orf89; Bcl10-interacting CARD protein
Target/Specificity
This C9orf89 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 30-59 amino acids from the N-terminal region of human C9orf89.
Dilution
WB~~1:100~500
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
C9orf89 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures.

C9orf89 Antibody (N-term) - Protein Information

Name C9orf89
Function
Plays a role in inhibiting the effects of BCL10-induced activation of NF-kappa-B. May inhibit the phosphorylation of BCL10 in a CARD-dependent manner
Cellular Location
Nucleus. Note=Co-expression with BCL10 induced translocation from nucleus to cytosol
Tissue Location
Expressed in ovary, testis, placenta, skeletal muscle, kidney, lung, heart and liver (at protein level) Expressed in thymus and brain

C9orf89 Antibody (N-term) - Related products

AP18337a: C9orf89 Antibody (N-term)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

C9orf89 plays a role in inhibiting the effects of BCL10-induced activation of NF-kappa-B. May inhibit the phosphorylation of BCL10 in a CARD-dependent manner.

REFERENCES

Matsuoka, S., et al. Science 316(5828):1160-1166(2007) Woo, H.N., et al. FEBS Lett. 578(3):239-244(2004)